Opko Health Stock Set to Open Lower After Trial Suspended

The healthcare stock is heavily shorted

Feb 1, 2019 at 9:13 AM
facebook X logo linkedin

The shares of Opko Health Inc. (NASDAQ:OPK) are down 3.8% in electronic trading, after the Florida-based diagnostics firm said its suspending a mid-stage trial studying OPK-88004, a selective androgen receptor modulator (SARM) used on patients with benign prostatic hyperplasia. This is offsetting news the Food and Drug Administration (FDA) approved the company's prostate specific antigen test.

Heading into today's trading, OPK stock had made strides off its late-December low of $2.34 -- up 57.3% to last night's close at $3.68. However, this rally ran out of steam near $3.90, a level that's contained the security since last October. Plus, the shares remain well off their July 17 annual high of $6.40.

Analysts have been slow to initiate coverage on Opko Health stock. Just two brokerages follow the stock, with one maintaining a "strong buy," and the other a tepid "hold." The average 12-month price target, meanwhile, sits all the way up at $10 -- territory the security hasn't charted since late 2016.

Short sellers will certainly be cheering, should today's price action pan out. While OPK stock is likely headed to the short-sale restricted list today, these bearish bettors control 59.3 million shares, representing 19.2% of the equity's float, or 12.5 times the average daily pace of trading.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI